Financial Performance

A new partnership lets parents order and track Ubers for their teens. It’s a logistical dream, but at what cost to privacy and adolescent independence?

Career colleges are booming as students flee AI, yet face intense pressure to adopt it. A new firm claims its bespoke approach can deliver massive ROI without the chaos.

A PR firm launches a daily financial newsletter for the lower middle market, betting that speed and focus can win over dealmakers in a crowded, vital field.

A new firm, Nortiva Bio, is launching with tech from MIT to turn daily pills into monthly doses, starting with a contraceptive backed by the Gates Foundation.

A new partnership between Charles River and Lilly TuneLab merges AI with nonclinical testing, aiming to fast-track new medicines and level the field for biotechs.

As hotels struggle with staff shortages, Croux expands its AI-powered platform to seven cities, promising a 96% show-up rate by treating staffing as a prediction problem.

Beyond simple comfort, your next HVAC is a major investment. We break down the tech, costs, and policies shaping the heat pump, furnace, and hybrid debate.

A new report reveals a startling trend: as AI adoption soars, financial firms are increasingly banning communication channels, a defensive move creating new risks.

A new three-year study shows listings promoted via agent-to-agent email blasts went pending 30% faster. The real story is how this advantage widens as markets cool.

As AI agents act with growing autonomy inside business tools, a new solution from MSPAlliance offers unprecedented visibility, shifting risk from a guess to a science.

With a key webinar ahead, Arrowhead Pharma is showcasing a trio of gene-silencing drugs. Can its TRiM™ platform upend a multi-billion dollar cardiometabolic market?

A new Slovak fintech offers zero-fee ETF investing to fight inflation. But what's the catch? We analyze the business model shaking up Central European finance.

Memo Therapeutics' Potravitug shows promise in a Phase II trial, offering the first real weapon against a common virus that threatens kidney transplants.

Asimov's AI-driven synthetic biology platform partners with McGill's Goodman Cancer Institute, aiming to break the manufacturing bottleneck for complex drugs.

A new spray-dried plasma could end reliance on freezers, transforming trauma care from the battlefield to rural ERs. But can Velico navigate the path to market?

With enhanced GMP cell banking suites, Minaris integrates manufacturing and testing in Philadelphia, aiming to accelerate development in the booming CGT market.

As Retevis offers military-tested two-way radios on Prime Day, businesses are discovering that true reliability doesn't come from a smartphone.

A new patent gives CervoMed a long runway for its dementia drug, but can this IP victory secure the massive funding needed to cross the finish line?

Hisense's VAR role at the World Cup is more than a tech deal. It's a high-stakes play to enhance game integrity, dominate a market, and redefine fan experience.

Lotus Tech's new sustainability report isn't just about green goals; it's a strategic play for investor trust with zero recalls and ambitious carbon targets.